European Journal of Vascular & Endovascular Surgery
Volume 25, Issue 1 , Pages 40-47 , January 2003

Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo

,Accepted 5 October 2002.

References 

  1. Califf RM, Ohman M, Frid DJ, et al.  Restenosis: the clinical issues. In: Topol EJ. Textbook of Interventional Cardiology. Philadelphia: WB Saunders; 1990;p. 63–94
  2. Rensing BJ, Vos J, Smits PC, et al.  Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasounic follow-up. Eur Heart J. 2001;22:2054–2057
  3. Comerota AJ. Endovascular and surgical revascularization for patients with intermittent claudication. Am J Cardiol. 2001;87:34D–43D
  4. Forrester JS, Fishbein M, Helfant R, et al.  A paradigm for restenosis based on cell biology clues for development of new preventative therapies. J Am Coll Cardiol. 1991;17:758–769
  5. Ip JH, Fuster V, Israel D. J. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. Am Coll Cardiol. 1991;17:77B–88B
  6. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanism. J Am Coll Cardiol. 1992;20:1284–1293
  7. Herrman JPR, Herman WRM, Vos J, et al.  Pharmacological approaches to the prevention of re-stenosis following angioplasty. The search for the holy grail? (part 1). Drugs. 1993;46:18–52
  8. Franklin SM, Faxon DP. Pharmacological prevention of re-stenosis after coronary angioplasty: review of the randomized clinical trials. Coron Artery Dis. 1993;4:232–242
  9. Watson HR, Belcher G, Horrocks M. Adjuvant medical therapy in peripheral bypass surgery. BJS. 1999;86:981–991
  10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1990;362:801
  11. Selzman CH, Meldrum DR, Cain BS, et al.  Interleukin-10 inhibits post-injury tumour necrosis factor-mediated human vascular smooth muscle proliferation. J Surg Res. 1998;80:352–356
  12. Lindner V, Lappi DA, Baird A, et al.  Role of basic fibroblast growth factor in vascular formation. Circ Res. 1991;68:106–113
  13. Ferns GAA, Raines EW, Sprugle KH, et al.  Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 1991;253:1129–1132
  14. Feder ME, Hofman GE. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Ann Rev Physiol. 1999;61:243–282
  15. Morimoto RI, Santoro MG. Stress-inducible responses and heat shock proteins: new pharmacological targets for cytoprotection. Nature Biotech. 1998;16:833–838
  16. Hedge RS, Zuo J, Voellmy R, et al.  Short circuiting stress protein expression via a tyrosine kinase inhibitor, Herbimycin A. J Cell Physiol. 1995;165:186–200
  17. Morris SD, Cumming DVE, Latchman DS, et al.  Specific induction of the 70kd heat stress proteins by the tyrosine kinase inhibitor Herbimycin A protects rat neonatal cardiomyocytes; A new pharmacolgical route to stress protein expression?. J Clin Invest. 1996;97:706–712
  18. Javadpour M, Kelly CJ, Chen G, et al.  Herbimycin-A attenuates ischaemia-reperfusion induced pulmonary infiltration. Eur J Vasc Endovasc Surg. 1998;16:377–382
  19. Rokutan K, Hirakawa T, Teshima S, et al.  Implications of heat shock/stress proteins for medicine and disease. J Med Invest. 1998;44:137–147
  20. Jacquier-Sarlin MR, Fuller K, Dinh-Xuan AT, et al.  Protective effects of hsp 70 in inflammation. Experimentia. 1994;50:1031–1038
  21. Hutter M, Sievers R, Barbosa V, et al.  Heat-shock protein induction in rat hearts. A direct correlation between the amount of heat shock protein induced and the degree of myocardial protection. Circulation. 1994;89:355–360
  22. Donnelly TJ, Sievers RE, Vissern FLJ, et al.  Heat-shock protein induction in rat hearts. A role for improved myocardial salvage after ischaemia and reperfusion?. Circulation. 1992;85:769–778
  23. Currie RW, Tanguay RM, Kingma JG. Heat shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation. 1993;87:963–971
  24. Stojadinovic A, Kiang J, Smallridge R, et al.  Induction of heat shock protein 72 protects against ischaemia/reperfusion in rat small intestine. Gastroenterology. 1995;109:505–515
  25. Garramore RR, Winters RM, Das DK, et al.  Reduction of skeletal muscle injury through stress conditioning using the heat-shock response. Plast Reconstr Surg. 1994;93:1242–1247
  26. McLaughlin R, Kelly CJ, Kay E, et al.  Diaphragmatic dysfunction secondary to experimental lower torso ischaemiareperfusion injury is attenuated by thermal pre-conditioning. BJS. 2000;87:301–305
  27. Stokes KY, Abdih HK, Kelly CJ, et al.  Thermotolerance attenuates ischaemia-reperfusion induced renal injury and increased expression of ICAM-1. Transplantation. 1996;62:1143–1149
  28. Neischis DG, Safford SD, Raghunath PN, et al.  Thermal pre-conditioning before rat arterial balloon injury; limitation of injury and sustained reduction of intimal thickening. Arterioscler Thromb Vasc Biol. 1998;18:120–126
  29. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327–333
  30. Connolly E, Bouchier-Hayes DJ, Kaye E, Leahy A, Fitzgerald D, Belton O. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. J Pharmacol Exp Ther. 2002;300:393–398
  31. Villar J, Ribeiro SP, Mullen JBM, et al.  Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med. 1994;22:914–921
  32. Slepian MJ, Massia SP, Whitesell L. Pre-conditioning of smooth muscle cells via induction of the heat shock response limits proliferation following mechanical injury. Biochem Biophys Res Comm. 1996;225:600–607
  33. Champagne MJ, Dumas P, Orlov SN, et al.  Protection against necrosis but not apoptosis by heat shock proteins in vascular smooth muscle cells. Hypertension. 1999;33:906–913
  34. Hamet P, Kaiser MA, Sun YL, et al.  HSP27 locus cosegregates with left ventricular mass independently of blood pressure. Hypertension. 1996;28:112–117
  35. Arrigo AP. Small stress proteins: chaperones that act as regulators of intracellular redox state and programmed cell death. Biol Chem. 1998;379:19–26
  36. Landry J, Chretien P, Lambert H, et al.  Heat shock resistance conferred by expression of the human HSP27 gene in rodent cells. J Cell Biology. 1989;109:7–15
  37. Ito H, Shimojo T, Fujisaki H, et al.  Thermal pre-conditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis. Life Sci. 1999;64:755–761
  38. Golomb G, Fishbein I, Banai S, et al.  Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis. 1996;125:171–182
  39. Bilder G, Wentz T, Leadley R, et al.  Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation. 1999;99:3292–3299
  40. Indolfi C, Eaposito G, Di Lorenzo E, et al.  Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 1995;92:1230–1235
  41. Perlman H, Maillard Luc, Krascinski K, et al.  Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation. 1997;95:981–987
  42. Pollman MJ, Hall JL, Gibbons GH. Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury; influence of redox state and cell phenotype. Circ Res. 1999;84:113–121
  43. Han DKM, Christian C, Haudenschild CC, et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267–277
  44. Alcocer F, Whitley D, Salazar J, et al.  Mutual exclusion of apoptosis and hsp70 in human vein intimal hyperplasia in vitro. J Surg Res. 2001;96:75–80
  45. O'Brien JE, Ormont ML, Yi Shi, et al.  Early injury to the media after saphenous vein grafting. Ann Thorac Surg. 1998;65:1273–1278
  46. Vayssier M, Polla BS. Heat shock proteins chaperoning life and death. Cell Stress & Chaperones. 1998;3:221–227
  47. Samali A, Orrenius S. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress & Chaperones. 1998;3:228–236
  48. Omara S, Iwai Y, Takahashi Y, et al.  Herbimycin, a new antibiotic produced by a strain of streptomyces. J Antibiotics. 1979;32:255–261
  49. Drummond MW, Holyoake TL. Tyrosine kinase inhibitors in the treatment of chronic myeloid leukaemia: so far so good?. Blood Rev. 2001;15:85–95
  50. Hirakawa T, Rokutan K, Nikawa T, Kishi K. Geranylgeranylacetone induces Heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology. 1996;111:345–357

☆ This work was funded by a research grant from the Health Research Board, Dublin, Ireland.

PII: S1078-5884(03)70184-1

doi: 10.1053/ejvs.2002.1793

European Journal of Vascular & Endovascular Surgery
Volume 25, Issue 1 , Pages 40-47 , January 2003

Article Tools

* Image Usage & Resolution